779 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
JNJ Johnson & Johnson $122.04 $327.33B Downtrend
Article Searches
Top Diabetes Stocks to Buy Today https://www.fool.com/investing/2018/05/31/top-diabetes-stocks-to-buy-today.aspx?source=iedfolrf0000001 May 31, 2018 - More people than ever are being diagnosed with diabetes, and big advances in treatment could make these diabetes stocks savvy investments.
Pfizer's Arthritis Drug Gets FDA Nod for Ulcerative Colitis http://www.zacks.com/stock/news/305816/pfizers-arthritis-drug-gets-fda-nod-for-ulcerative-colitis?cid=CS-ZC-FT-305816 May 31, 2018 - The FDA approves Pfizer's (PFE) sNDA seeking label expansion in third indication for Xeljanz to include moderately to severely active ulcerative colitis.
How to Find a Growth Stock https://www.fool.com/investing/2018/05/30/how-to-find-a-growth-stock.aspx?source=iedfolrf0000001 May 30, 2018 - Identifying businesses built for growth is easy once you know where to look.
These 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys? https://www.fool.com/investing/2018/05/29/these-3-stocks-shot-up-50-in-2017-are-they-still-b.aspx?source=iedfolrf0000001 May 29, 2018 - Why an airplane giant, a drugmaker, and an alcoholic beverage specialist could each see more market-thumping gains ahead.
3 Likely Reasons Geron Stock Is Sizzling Hot Right Now https://www.fool.com/investing/2018/05/25/3-likely-reasons-geron-stock-is-sizzling-hot-right.aspx?source=iedfolrf0000001 May 25, 2018 - This biotech stock is skyrocketing. Here's why -- maybe.
What Is Geron Corporation's Downside Risk? https://www.fool.com/investing/2018/05/25/what-is-geron-corporations-downside-risk.aspx?source=iedfolrf0000001 May 25, 2018 - Management's bold moves have been steadily stemming concerns about the company's future.
Dow 30 Stock Roundup: GE's Transportation Unit to Merge With Wabtec, J&J & Glaxo's HIV Drug Gets EU Approval http://www.zacks.com/stock/news/305045/dow-30-stock-roundup-ges-transportation-unit-to-merge-with-wabtec-jj-glaxos-hiv-drug-gets-eu-approval?cid=CS-ZC-FT-305045 May 25, 2018 - The Dow endured another volatile week marked by key geopolitical developments.
AbbVie's Imbruvica's Phase III Study Meets Primary Endpoint http://www.zacks.com/stock/news/305024/abbvies-imbruvicas-phase-iii-study-meets-primary-endpoint?cid=CS-ZC-FT-305024 May 25, 2018 - AbbVie's (ABBV) phase III iLLUMINA study evaluating Imbruvica in combination with Gazyva meets its primary endpoint of improvement in progression-free survival.
Novartis Gets Approval for Remicade Biosimilar in Europe http://www.zacks.com/stock/news/304933/novartis-gets-approval-for-remicade-biosimilar-in-europe?cid=CS-ZC-FT-304933 May 24, 2018 - Novartis' (NVS) Sandoz wins approval for a biosimilar version of Remicade in Europe, which should further strengthen its biosimilars portfolio.
Why Geron Corporation Stock Is Heating Up https://www.fool.com/investing/2018/05/23/why-geron-corporation-stock-is-heating-up.aspx?source=iedfolrf0000001 May 23, 2018 - Geron's stock is blasting higher this week, but the exact reason isn't clear.

Pages: 123456...78

Page 1>